Impact of Critical Material Attributes (CMAs)-Particle Shape on Miniature Pharmaceutical Unit Operations.

导出 OA

翻译打印收藏纠错

第一作者： Mohammad A,Azad

第一单位： Department of Chemical Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA, 02139, USA.

作者： Mohammad A,Azad ^[1] ; Gerard,Capellades ^[2] ; Allison B,Wang ^[1] ; David M,Klee ^[3] ; Gregory,Hammersmith ^[1] ; Kersten,Rapp ^[1] ; David,Brancazio ^[1] ; Allan S,Myerson ^[4]

作者单位： Department of Chemical Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA, 02139, USA. ^[1] Department of Chemical, Biological and Bioengineering, North Carolina A& T State University, 1601 E. Market Street, Greensboro, NC, 27411, USA. ^[2] Department of Chemical Engineering, Henry M. Rowan College of Engineering, Rowan University, 201 Mullica Hill Road, Glassboro, NJ, 08028, USA. ^[3] On Demand Pharmaceuticals, 3 Park Ave, 33rd floor, New York, NY, 10016, USA. ^[4] Department of Chemical Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA, 02139, USA. myerson@mit.edu. ^[5]

关键词 Ciprofloxacin HCl critical material attributes (CMAs)direct compressible tablets miniature pharmaceutical unit operations needle-shaped particles